|
|
Volumn 23, Issue 11, 1998, Pages 1190-1198
|
|
Orbofiban acetate. Platelet antiaggregatory, fibrinogen gpIIb/IIIa receptor antagonist
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 [1 [3 (4 PIPERIDINYL)PROPIONYL]NIPECOTOYLAMINO] 3 (3 PYRIDYL)PROPIONIC ACID;
3 [1 [3 (4 PIPERIDINYL)PROPIONYL]NIPECOTOYLAMINO]PROPIONIC ACID;
3 [3 (4 AMIDINOBENZAMIDO)PROPIONAMIDO] 2 (4 ETHYLBENZENESULFONAMIDO)PROPIONIC ACID;
3 [[4 [4 [AMINO(ETHOXYCARBONYLIMINO)METHYL]PHENYL] 2 THIAZOLYL](1 ETHOXYCARBONYLMETHYL 4 PIPERIDINYL)AMINO]PROPIONIC ACID ETHYL ESTER;
4 (4 AMIDINOBENZOYLGLYCYL) 3 METHOXYCARBONYLMETHYL 2 OXO 1 PIPERAZINEACETIC ACID;
4 [[3 [4 [IMINO[(METHOXYCARBONYL)AMINO]METHYL]PHENYL] 2 OXO 5 OXAZOLIDINYL]METHYL] 1 PIPERAZINEACETIC ACID ETHYL ESTER;
[[[3 [4 (AMINOIMINOMETHYL)PHENYL] 4,5 DIHYDRO 5 ISOXAZOLYL]ACETYL]AMINO] N [(3 METHYLPHENYL)SULFONYL]ALANINE;
ABCIXIMAB;
CT 50352;
DMP 757;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FRADAFIBAN;
LAMIFIBAN;
LEFRADAFIBAN;
LOTRAFIBAN;
ME 3277;
N ACETYLCYSTEINYLASPARAGINYLPROLYLARGINYLGLYCYLASPARTYL(O METHYLTYROSYL)ARGINYLCYSTEINAMIDE CYCLIC 1,9 DISULFIDE;
ORBOFIBAN;
ROXIFIBAN;
SIBRAFIBAN;
T 250;
TIROFIBAN;
TRM 147;
UNCLASSIFIED DRUG;
XEMILOFIBAN;
YM 337;
ANIMAL EXPERIMENT;
DOG;
DRUG SYNTHESIS;
FIBRINOLYTIC THERAPY;
NONHUMAN;
REVIEW;
THROMBOCYTE AGGREGATION;
THROMBOSIS;
|
|
EID: 0032416061
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1998.023.11.473093 Document Type: Review |
|
Times cited : (7)
|
|
References (27)
|
